Sejeong Shin Selected Research

Carcinogenesis

10/2019	Dynamic Incorporation of Histone H3 Variants into Chromatin Is Essential for Acquisition of Aggressive Traits and Metastatic Colonization.
4/2010	ERK2 but not ERK1 induces epithelial-to-mesenchymal transformation via DEF motif-dependent signaling events.
6/2006	Ras stimulation of E2F activity and a consequent E2F regulation of integrin alpha6beta4 promote the invasion of breast carcinoma cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sejeong Shin Research Topics

Disease

9	Neoplasms (Cancer) 01/2022 - 04/2005
4	Carcinoma (Carcinomatosis) 10/2019 - 04/2005
4	Breast Neoplasms (Breast Cancer) 01/2014 - 03/2006
3	Carcinogenesis 10/2019 - 06/2006
2	Neoplasm Metastasis (Metastasis) 10/2019 - 01/2012
2	Melanoma (Melanoma, Malignant) 01/2018 - 11/2006
1	Sjogren's Syndrome (Sjogren Syndrome) 01/2023
1	Tuberous Sclerosis (Bourneville's Disease) 01/2016
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2016
1	Lymphangioleiomyomatosis (Lymphangiomyomatosis) 01/2016
1	Insulin Resistance 11/2011
1	Fibrosarcoma 11/2006
1	Hypoxia (Hypoxemia) 04/2005

Drug/Important Bio-Agent (IBA)

3	Proteins (Proteins, Gene)FDA Link 01/2023 - 04/2005
3	Integrin alpha6beta4IBA 06/2006 - 04/2005
2	Transcription Factors (Transcription Factor)IBA 10/2019 - 06/2006
2	Mechanistic Target of Rapamycin Complex 1IBA 08/2017 - 01/2016
2	IntegrinsIBA 01/2012 - 03/2006
1	Heterogeneous-Nuclear Ribonucleoproteins (Informatin)IBA 01/2023
1	Insulin-Like PeptidesIBA 01/2023
1	AntigensIBA 01/2023
1	Carrier Proteins (Binding Protein)IBA 01/2023
1	Janus KinasesIBA 01/2023
1	Insulin ReceptorIBA 01/2023
1	Messenger RNA (mRNA)IBA 01/2023
1	Interleukin-6 (Interleukin 6)IBA 01/2023
1	Heterogeneous-Nuclear Ribonucleoprotein KIBA 01/2023
1	Histones (Histone)IBA 10/2019
1	ChromatinIBA 10/2019
1	Histone ChaperonesIBA 10/2019
1	EnzymesIBA 01/2018
1	90-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 90 kDa)IBA 01/2018
1	Glucose (Dextrose)FDA LinkGeneric 01/2018
1	TOR Serine-Threonine KinasesIBA 08/2017
1	MTOR InhibitorsIBA 08/2017
1	trans-sodium crocetinate (crocetin)IBA 01/2016
1	Casein Kinases (Casein Kinase)IBA 01/2014
1	Peptide Initiation Factors (Initiation Factor)IBA 01/2014
1	Ribosomal Protein S6 Kinases (S6 Kinase)IBA 11/2011
1	Glycogen Synthase Kinase 3IBA 11/2011
1	butyl phosphorotrithioate (DEF)IBA 04/2010
1	Matrix Metalloproteinases (MMPs)IBA 11/2006
1	Tissue Inhibitor of MetalloproteinasesIBA 11/2006
1	isoginkgetinIBA 11/2006
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 11/2006
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 11/2006
1	Integrin beta4IBA 06/2006
1	ras ProteinsIBA 06/2006
1	Small Interfering RNA (siRNA)IBA 03/2006
1	ErbB Receptors (EGF Receptor)IBA 03/2006
1	Membrane Proteins (Integral Membrane Proteins)IBA 04/2005
1	Glycogen Synthase Kinase 3 betaIBA 04/2005
1	TubulinIBA 04/2005
1	Colchicine FDA LinkGeneric 04/2005

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 01/2022
1	Therapeutics 01/2016